Transformation of algal cells

Information

  • Patent Grant
  • 8119859
  • Patent Number
    8,119,859
  • Date Filed
    Monday, June 8, 2009
    15 years ago
  • Date Issued
    Tuesday, February 21, 2012
    12 years ago
Abstract
Exemplary methods include a method for transforming an algal cell by preparing a transformation construct, preparing a particle for bombarding the algal cell, adhering the transformation construct to the particle, bombarding the algal cell with the particle, and growing the algal cell into a colony. The transformation construct is replicated within a nuclear genome of the algal cell and the growing of the algal cell is in a nutrient medium. Another exemplary method may include a method for genetically modifying an algal cell, by adding nucleic acid to the algal cell while the algal cell is suspended in a solution of low conductivity, introducing the nucleic acid into the algal cell by application of an electrical pulse resulting in a transformed algal cell, and selecting a colony that includes the transformed algal cell.
Description
REFERENCE TO SEQUENCE LISTINGS

The present application is filed with sequence listing(s) attached hereto and incorporated by reference.


BACKGROUND OF THE INVENTION

1. Field of the Invention


This invention relates to molecular biology, and more specifically to the transformation of algal cells.


2. Description of Related Art


Transformed algae cells may be useful in aquaculture production. The transformation of small algal cells with strong cell walls, however, is difficult to achieve. Accordingly, there is a need for improved methods of algal cell transformation.


SUMMARY OF INVENTION

Exemplary methods include a method for transforming an algal cell by preparing a transformation construct, preparing a particle for bombarding the algal cell, adhering the transformation construct to the particle, bombarding the algal cell with the particle, and growing the algal cell into a colony. The transformation construct is replicated within a nuclear genome of the algal cell and the growing of the algal cell is in a nutrient medium.


Another exemplary method may include a method for genetically modifying an algal cell, by adding nucleic acid to the algal cell while the algal cell is suspended in a solution of low conductivity, introducing the nucleic acid into the algal cell by application of an electrical pulse resulting in a transformed algal cell, and selecting a colony that includes the transformed algal cell.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a sequence of an exemplary transformation construct.



FIG. 2 illustrates an exemplary method for transforming an algal cell with a particle gun.



FIG. 3 shows an exemplary polymerase chain reaction result obtained using ble primers as described in connection with Example One.



FIG. 4 shows the exemplary polymerase chain reaction result obtained as described in connection with Example Two.



FIG. 5 shows the number of algal cell transformants obtained based on the field strength of electroporation applied to perform the transformation as described in connection with Example Three.



FIG. 6 shows the number of transformants obtained under exemplary optimal electroporation conditions, while varying the amount of transformation construct DNA used as described in connection with Example Four.



FIG. 7 illustrates an exemplary method for transforming an algal cell with electroporation.





DETAILED DESCRIPTION OF THE INVENTION

Provided herein are exemplary methods for transforming algal cells. Transformed algae cells may be useful in aquaculture production. The transformation of small algal cells with strong cell walls, however, is difficult to achieve. Various exemplary embodiments of the present invention are useful in the efficient transformation of Nannochloropsis, a microalga of about 3-5 micrometers in size.


Typically, gold particles having a size of about 0.6 micrometers are used in biolistic transformation of algae smaller than about 5 micrometers. A transformation vector or transformation construct is precipitated onto the gold particles, and the gold particles carrying the transformation construct are propelled through the cell walls of the algae. The transformation efficiency of Nannochloropsis with this method is very low.


According to the various exemplary methods provided herein, aggregates of gold particles are broken into smaller fragments to increase transformation efficiency. Using a 1510 Branson Bath Sonicator, 0.6 micrometer gold particles are sonicated for one hour just prior to precipitating a transformation construct onto the gold particles. Using the sonicated gold particles or beads, fourteen micrograms of transformation construct may produce approximately twenty zeocine resistant transformants. Thus, this exemplary embodiment provides about a twenty-fold increase in transformation efficiency over currently available methods.


An alternative exemplary embodiment uses an improved electroporation method to transform algal cells. In electroporation, algal cells are subjected to an electric current that opens transient pores in the membranes of the algal cells. A transformation vector may pass through an open pore, eventually leading to the successful transformation of the algal cell. Using a Biorad Genpulser I electroporator set to the exponential protocol, the following electroporation conditions were used: 2200V, 500Ω shunt resistor, 50 μF capacity, 2 mm gap cuvette. When 10^9 cells have been used in iso-osmotic non electrolyte buffer (resistance higher than 1100Ω) in a volume of 100 microliters, typical time constants τ of 20-24 ms have been reported by the device. This approach produced hundreds of zeocine resistant transformants per microgram of transformation construct used.



FIG. 1 shows the sequence of an exemplary transformation construct. The exemplary transformation construct 100 includes a promoter sequence 102, DNA encoding a transcribed but untranslated 5′ region (“UTR”) 104, an intron 106, a ble gene 108 and DNA encoding a 3′ UTR 110. The transformation construct may comprise any number of promoters, genes, and/or other nucleic acid polymers (naturally occurring or synthetic) and/or their analogs, or other compounds that do not interfere with the ability of the transformation construct to enter the algal cell or the algal genome, or to function. In some embodiments, additional nucleotides may appear in the transformation construct to facilitate or direct the insertion of the construct (or any part thereof) into a desired location in the genome.


The various exemplary methods described herein may be employed using the exemplary transformation vectors or transformation constructs PL90, H8 and B9 as described in U.S. Non-Provisional Patent Application Ser. No. 12/480,635 filed on Jun. 8, 2009, titled “VCP-Based Vectors for Algal Cell Transformation,” which is hereby incorporated by reference. The difference between the three exemplary vector constructs is the type of selection marker gene (SG) used: the sh ble gene (PL90), the hygromycin B phosphotransferase gene (H8), or the blastocidin S deaminase (B9) gene.



FIG. 2 illustrates an exemplary method for transforming an algal cell with a particle gun.


At step 205, a desired transformation construct is prepared. According to one exemplary embodiment, the transformation construct may be either the PL90 transformation vector, the H8 transformation vector, or the B9 transformation vector.


At step 210, small DNA-binding particles are prepared. According to one exemplary embodiment, 0.6 μm gold particles are sonicated in buffer for one hour.


At step 215, the transformation construct is adhered to the small DNA-binding particles. In one exemplary method, transformation constructs are precipitated onto the gold particles.


At step 220, algal cells are bombarded with the gold particles having the transformation constructs precipitated onto them. Nannochloropsis cells, according to one exemplary method, are bombarded with fourteen micrograms of transformation construct DNA that has been precipitated onto 0.42 mg of the 0.6 μm gold particles.


At step 225, the algal cells are grown into colonies on selective medium. According to one exemplary embodiment, if the transformed cells produce a large quantity of a desired gene product, the cells may be further processed to collect the desired product. One having ordinary skill in the art will recognize that many appropriate buffers, media, and/or methods of product collection may be used.


EXAMPLE ONE


Nannochloropsis oceanica cells were grown in low light (85 μE/(m2*s)) to mid log phase in F2 media, 50% seawater (See e.g., Guillard, R. R. L. and Ryther, J. H. 1962. Studies of marine planktonic diatoms. I. Cyclotella nana Hustedt and Detonula confervacea Cleve. Can. J. Microbiol. 8: 229-239). Nannochloropsis cells were then pelleted at 2500 g for 15 min. The pellet was then resuspended in fresh media. 5*10^9 resuspended cells were spread on petri dishes (F2 media, 50% seawater, 1% Bactoagar™ from DIFCO) and allowed to dry. 0.6 μm gold particles (Biorad) were coated essentially as recommended by Biorad with transformation vector PL90. The plated cells were then bombarded with microparticles (coated with transformation construct DNA as recommended by Biorad) by a particle gun (Biolistic PDS-1000/He particle gun Bio-Rad) at vacuum pressure of 29 mm Hg utilizing the heptameric adapter from Biorad. All different stages were used in combination with 3 different rupture discs (1100 PSI, 1350 PSI, 1550 PSI) provided by Biorad. Cells were subsequently resuspended in 10 ml fresh F2 Medium (half salinity) and allowed to recover overnight under low light (˜10-25 μE/(m2*s)). 0.5*10^7 cells were then plated on agar plates (0.8% Bactoagar™ from DIFCO) containing the selection agent (2 μg/ml zeocine, μg/ml 300 hygromycin or 50 μg/ml blasticidin, depending on the transformation construct used) and incubated at 25° C. at ˜50 μE/(m2*sec). Negative control DNA was linearized pJet1 vector DNA (Fermentas). Growth of colonies could be observed after ˜2-3 weeks. Colonies were then analyzed for the presence of the selection marker gene. Colonies on selective media were never obtained in experiments utilizing the control DNA. Only utilization of 1350 PSI rupture disc, stage 1 (uppermost stage, just underneath heptameric adapter) and 1550 PSI rupture disc stage 2 yielded a few transformants under these conditions.


To proof for the presence of transformation construct within the cells (and thus that the transformation experiment was a success), a single colony was picked and restreaked on unselective medium and allowed to grow for approximately one week. Cells were then scraped (˜10 μg cells), washed 3 times in F2-50% seawater, incubated with 30 units DNAse I in DNAse I buffer (Fementas) 1 hour at 37° C. Cells were then washed once in F2-50% seawater and resuspended in 50 μl F2-50% seawater. Cells were pelleted and the supernatant collected; cells were resuspended in 50 μl ddH20. Cell and supernatant fractions were incubated 7 minutes at 95° C.; 5 μl each fraction were subjected to PCR (50 μl reaction volume) with specific primers against the ble gene (rev: 5′TTA GTC CTG CTC CTC GGC CAC GAA3′, for: 5′ATG GCC AAG TTG ACC ACT GCC GT3′).


The PCR program was:


1. 94 C, 3 min, 1 cycle;


2. 94 C, 15 sec;


3. 58 C, 30 sec;


4. 72 C, 30 sec (steps 2-4 are amplification stage, 38 cycles);


5. 72 C, 5 min; and


6. 4 C, cool down and keep temperature.



FIG. 3 shows the exemplary polymerase chain reaction result obtained using ble primers as described in connection with Example One.


EXAMPLE TWO

We followed the procedures of Example One, except this time utilizing a 1510 Branson Bath Sonicator, 0.6 μm gold particles were sonicated for 1-hour just prior to DNA precipitation onto beads. Using the sonicated beads, 14 μg DNA produced approximately 20 zeocine-resistant transformants.


Detailed Procedure.


Growth and preparation of cells: the cells were grown in 2 L flasks in F2 medium (containing seawater of half salinity) to early log phase. The cells were then harvested by centrifugation for 10 min. at 2500 and gently resuspended in fresh F2 medium. 5*10^9 cells (in ˜400 μl) were then plated on an agar plate (containing 1% Bactoagar™ from DIFCO) and allowed to dry for ˜20 minutes in a sterile hood.


Preparation of Particles.


Different sizes and materials of particles were used (all obtained from Biorad), i.e. Tungsten particles 0.7 and 1 μm average diameter and gold particles 1 μm or 0.6 μm average diameter. Prior to the precipitation of the DNA onto the particles (the micro carrier), the particles were resuspended in ddH2O and sonicated for 1 hour in a 1510 Branson Bath Sonicator. 3 mg particles were coated with 100 μg linearized transformation construct DNA as described elsewhere (see user manual Biolistic PDS-1000/He particle gun from Bio-Rad) and resuspended in 500 μl Ethanol after 2 washing steps in the same volume ethanol. 10 μl of this DNA coated particle solution (‘the microcarrier’) was pipetted onto each macrocarrier which was fitted subsequently into the Hepta Adapter (optional component of the Biolistic® PDS-1000/He Particle Delivery system). Thus, each shot with the particle gun provided 7×2 μg=14 μg DNA precipitated on micro carrier. Coated particles were used for biolistic transformation within an hour.


Delivery of Particles to Cells.


The petri dish containing the cells was placed on the corresponding stage within the particle delivery system (stage 1 being the nearest to the heptamer adapter, stage 3 being the one most far away). One of three different rupture discs (Biorad) was used: 1100 psi, 1350 psi, 1550 psi. Vacuum was generally applied to 29 mm Hg (obtained within ˜20 sec.) and the He pressure was increased at max speed in order to provide the He shock wave after rupture of the rupture disc. The pressure in the delivery chamber was instantly increased at maximal rate (less than 10 sec until atmospheric pressure was reached) and the petri dish with the bombarded cells was recovered.


Post Delivery Treatment of Cells.


The cells were gently scraped off the plate resuspended in 10 ml of F2 medium (half salinity compared to seawater) and allowed to recover in low light (˜10 μE/(m2*s)) over night. Next day, 0.5*10^7 cells were plated on F2 agar plates (petri dish, F2 medium with half salinity compared to seawater and 0.8% Bactoagar™ from DIFCO) and the respective selection agent. Plates were incubated at 25° C. at 50 μE/(m2*sec). Colonies were visible after ˜2-3 weeks.


Results.


1. From all the particles tested, only the 0.6 μm gold particles produced transformants.


2. We tested all different combinations of stage position (within the particle delivery system) and rupture disc.


3. A major difference was observed when we pretreated the gold particles with ultrasound.


The following table reflects the quantity of transformants observed when using different experimental parameters. The vector used in these experiments was PL90 conferring resistance against the drug zeocine.















Gold particles pretreatment1














no
no
no
yes
yes
yes









Rupture disc














1100
1350
1550
1100
1350
1550



psi
psi
psi
psi
psi
psi


















Stage
1
0
1
0
11
4
77



2
0
0
2
25
4
22



3
0
0
0
8
4
5






1gold particles were washed and then disrupted by 1 h ultra sound treatment







These results indicate that:


1. Pretreatment of the 0.6 μm gold particles by ultra sound dramatically increases the transformation efficiency.


2. That the transformation efficiency is highest at 1100 Psi pressure (rupture disc) and if the petri dish containing the cells is localized on stage 2.


3. The vector PL90 may be used for the nuclear transformation of Nannochloropsis by conferring resistance against the drug zeocine.



FIG. 4 shows the exemplary polymerase chain reaction result obtained as described in connection with Example Two.


EXAMPLE THREE

Transformation via Electroporation.


Detailed Procedure.


Growth and Preparation of Cells.



Nannochloropsis oceanica was grown in 2 L flasks in F2 medium (containing seawater of half salinity) to mid log phase. The cells were then harvested by centrifugation for 10 min. at 2500 and gently resuspended in 375 mM sorbitol. The cells were washed several times in 375 mM sorbitol solution in order to minimize conductivity of remaining medium. The cells were finally resuspended to a final concentration of 10^10 cells/ml and used for transformation within an hour.


Electroporation.


Electroporation was performed in a Biorad GenPulser I Electroporator utilizing 2 mm cuvettes. 100 μl cells at 10^10 cells/ml were pipetted into a 2 mm cuvette and varying amounts of transformation construct in <5 μl volume ddH2O added. The cuvette containing the DNA-cell mixture was gently snipped for mixing and then placed into the electroporation chamber.


Device settings were exponential decay protocol with 500 Ohm Shunt resistance and 50 μF capacity, 2 mm Gap


Post Delivery Treatment of Cells.


After electroporation the cells were allowed to stay in the cuvette for 3 minutes before they were recovered and resuspended in 10 ml F2 medium (half salinity). After an overnight incubation in low light (˜10 μE/(m2*s), 0.5*10^7 cells were plated on F2 agar plates and the respective selection agent. Plates were incubated at 25° C. at 50 μE/(m2*sec). Colonies were visible after ˜2-3 weeks.


Results.


In initial experiments, we used 0.5 μg DNA/100 μl cell suspension and varied the voltage. We routinely measured electrical resistance of the cell-DNA mixture with the respective option in the Biorad GenPulser I Electroporator to ensure that resistance was >1100 Ohm. The actual electroporation usually returned exponential decay times τ of 20-24 ms. Initially, when performing these experiments with varying field strengths we got a single transformant (again we used the PL90 vector linearized and performed selection on agar plates containing zeocine) at the highest field strength initially tried (which was 1000V, =5 kV/cm). 5 kV/cm is a very high field strength and we did not expect that we might obtain transformants at all at such a high field strength. Since we obtained a single transformant at this high voltage we performed electroporations in additional experiments at very high voltages.



FIG. 5 shows the number of algal cell transformants obtained based on the field strength of electroporation applied to perform the transformation as described in connection with Example Three. The result of this experiment as shown in FIG. 5 was very surprising: transformation was successful at field strengths equal or higher than 8 kV/cm and efficiency peaked at 10.5 kV/cm. Note that applied field strengths for the electroporation of algae are typically factor 10 lower. Higher Field strengths than 12000V/cm were not possible to apply (cuvettes arced).


We conclude that we can transform Nannochloropsis with the vector PL90 if we treat the cells as indicated above.


EXAMPLE FOUR

Ideal Electroporation.


Parameters are (within Biorad GenPulser I Electroporator): 10^9 cells in 100 μl 375 mM sorbitol (washed several times), 500 Ohm shunt resistor, 2 mm gap cuvette, 10500 volt/cm (=2100V/2 mm), exponential decay program.


We then tested the efficiency of transformation by adding varying amounts of DNA to the electroporation cuvette (again containing 10^9 cells in 100 μl).



FIG. 6 shows the number of transformants obtained under exemplary optimal electroporation conditions, while varying the amount of transformation construct DNA used as described in connection with Example Four. We observed a linear increase in the number of transformants obtained based on increasing the amount of transformation construct DNA used. For example, 3 μg of transformation construct DNA added during a single electroporation experiment yielded approximately 9000 transformants, 1.5 μg of transformation construct DNA yielded approximately 4500 transformants. This result indicates that no saturation with DNA occurred and that the transformation method via electroporation which we established is extremely efficient.



FIG. 7 illustrates an exemplary method for transforming an algal cell with electroporation.


At step 705, a desired transformation construct is prepared. According to one exemplary embodiment, the transformation construct may be either the PL90 transformation vector, the H8 transformation vector, or the B9 transformation vector.


At step 710, the transformation construct is added to algal cells, while the algal cells are suspended in a solution of low conductivity. In various exemplary embodiments, the solution is a sorbitol solution.


At step 715, the transformation construct is introduced into the algal cells by application of an electrical pulse, resulting in transformation of the algal cells. According to some exemplary embodiments, the electrical pulse is applied with a field strength of higher than approximately 10,000 V/cm, and with a shunt resistor of greater than approximately 100 OHM.


At step 720, the algal cells are grown into colonies on selective medium. According to one exemplary embodiment, if the transformed cells produce a large quantity of a desired gene product, the cells may be further processed to collect the desired product. One having ordinary skill in the art will recognize that many appropriate buffers, media, and/or methods of product collection may be used.


While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Thus, the breadth and scope of a preferred embodiment should not be limited by any of the above-described exemplary embodiments.

Claims
  • 1. A method for transforming an algal cell, the method comprising: preparing a transformation construct, the transformation construct including a gene involved in lipid biosynthesis;preparing a particle for bombarding the algal cell;adhering the transformation construct to the particle;bombarding the algal cell with the particle;growing the algal cell into a colony;wherein the particle is a gold particle smaller than or equal to approximately 1 micrometer average diameter; andwherein the preparing of the gold particle includes sonicating the gold particle with ultrasound prior to the adhering of the transformation construct to the gold particle.
  • 2. The method of claim 1, wherein the transformation construct is replicated within a nuclear genome of the algal cell.
  • 3. The method of claim 1, wherein the growing of the algal cell is in a nutrient medium.
  • 4. The method of claim 1, wherein the transformation construct is a nucleic acid in an expression cassette.
  • 5. The method of claim 4, wherein the expression cassette further comprises: a promoter functional in the algal cell operably linked to the gene involved in lipid biosynthesis;a selectable transformation marker gene; anda termination region functional in the algal cell operably linked to the gene involved in lipid biosynthesis.
  • 6. The method of claim 5, wherein the selectable transformation marker gene is a gene capable of conferring antibiotic resistance to the algal cell.
  • 7. The method of claim 6, the method further comprising:
  • 8. The method of claim 1, wherein the algal cell is an auxotrophic mutant.
  • 9. The method of claim 1, wherein the transformation construct includes a sh ble gene.
  • 10. The method of claim 1, wherein the transformation construct includes a hygromycin B phosphotransferase gene.
  • 11. The method of claim 1, wherein the transformation construct includes a nitrate reductase gene.
  • 12. The method of claim 1, wherein the transformation construct includes a blastocidin S deaminase gene.
  • 13. The method of claim 1, wherein the adhering of the transformation construct to the particle includes precipitating DNA of the transformation construct to the particle.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims the benefit and priority of U.S. Provisional Patent Application Ser. No. 61/059,672 filed on Jun. 6, 2008, titled “VCP-Based Vector for Nannochloropsis Transformation,” which is hereby incorporated by reference. The present application is related to U.S. Non-Provisional patent application Ser. No. 12/480,635 filed on Jun. 8, 2009, titled “VCP-Based Vectors for Algal Cell Transformation,” which is hereby incorporated by reference.

US Referenced Citations (70)
Number Name Date Kind
1926780 Lippincott Sep 1933 A
3468057 Buisson Sep 1969 A
3962466 Nakabayashi Jun 1976 A
4003337 Moore Jan 1977 A
4267038 Thompson May 1981 A
4365938 Warinner Dec 1982 A
4658757 Cook Apr 1987 A
5105085 McGuire et al. Apr 1992 A
5478208 Kasai Dec 1995 A
5527456 Jensen Jun 1996 A
5661017 Dunahay et al. Aug 1997 A
5668298 Waldron Sep 1997 A
5823781 Hitchcock et al. Oct 1998 A
6027900 Allnutt et al. Feb 2000 A
6117313 Goldman Sep 2000 A
6143562 Trulson et al. Nov 2000 A
6297054 Maliga et al. Oct 2001 B1
6372460 Gladue et al. Apr 2002 B1
6736572 Geraghty May 2004 B2
6831040 Unkefer et al. Dec 2004 B1
6871195 Ryan et al. Mar 2005 B2
7244609 Drocourt et al. Jul 2007 B2
7381326 Haddas Jun 2008 B2
7410637 Sayre et al. Aug 2008 B2
7547551 Schuler et al. Jun 2009 B2
20030140021 Ryan et al. Jul 2003 A1
20030143743 Schuler et al. Jul 2003 A1
20030199490 Antoni-Zimmermann et al. Oct 2003 A1
20030211089 Sayre et al. Nov 2003 A1
20040161364 Carlson Aug 2004 A1
20040262219 Jensen Dec 2004 A1
20050064577 Berzin Mar 2005 A1
20050095569 Franklin May 2005 A1
20050124010 Short et al. Jun 2005 A1
20050170479 Weaver et al. Aug 2005 A1
20050181345 Bradbury et al. Aug 2005 A1
20050260553 Berzin Nov 2005 A1
20060031087 Fox et al. Feb 2006 A1
20060044259 Hotelling et al. Mar 2006 A1
20060045750 Stiles Mar 2006 A1
20060101535 Forster et al. May 2006 A1
20060122410 Fichtali et al. Jun 2006 A1
20060155558 Corpening Jul 2006 A1
20060166243 Su et al. Jul 2006 A1
20060192690 Philipp Aug 2006 A1
20070178451 Deng et al. Aug 2007 A1
20080118964 Huntley et al. May 2008 A1
20080120749 Melis et al. May 2008 A1
20080160488 Younkes et al. Jul 2008 A1
20080160591 Willson et al. Jul 2008 A1
20080194029 Hegemann et al. Aug 2008 A1
20080293132 Goldman et al. Nov 2008 A1
20090029445 Eckelberry et al. Jan 2009 A1
20090061928 Lee et al. Mar 2009 A1
20090148931 Wilkerson et al. Jun 2009 A1
20090234146 Cooney et al. Sep 2009 A1
20090317878 Champagne et al. Dec 2009 A1
20090317904 Vick et al. Dec 2009 A1
20090319338 Parks et al. Dec 2009 A1
20090325270 Vick et al. Dec 2009 A1
20100068772 Downey Mar 2010 A1
20100100520 Dargue et al. Apr 2010 A1
20100198659 Meltzer et al. Aug 2010 A1
20100210003 King Aug 2010 A1
20100210832 Kilian et al. Aug 2010 A1
20100314324 Rice et al. Dec 2010 A1
20100323387 Bailey et al. Dec 2010 A1
20100330643 Kilian et al. Dec 2010 A1
20110059495 Bailey et al. Mar 2011 A1
20110091977 Kilian et al. Apr 2011 A1
Foreign Referenced Citations (8)
Number Date Country
1627764 Jun 2005 CN
1867140 Nov 2006 CN
1956335 May 2007 CN
WO2004106238 Dec 2004 WO
WO2007084078 Jul 2007 WO
WO2008060571 May 2008 WO
WO2008060571 May 2008 WO
WO2008060571 May 2008 WO
Related Publications (1)
Number Date Country
20090317857 A1 Dec 2009 US
Provisional Applications (1)
Number Date Country
61059672 Jun 2008 US